Cho, Hyun Jin <br/><br/>
Prognostic value of survivin expression in stage III non-small cell lung cancer patients treated with platinum-based therapy.  [electronic resource] 

 -  Surgical oncology  Dec 2015 
 - 329-34 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1879-3320 
<br/><br/><label>Standard No.: </label>10.1016/j.suronc.2015.09.001  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Biomarkers, Tumor--metabolism<br/>Carcinoma, Adenosquamous--drug therapy<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Carcinoma, Squamous Cell--drug therapy<br/>Chemoradiotherapy<br/>Cisplatin--administration & dosage<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunoenzyme Techniques<br/>Inhibitor of Apoptosis Proteins--metabolism<br/>Lung Neoplasms--drug therapy<br/>Lymph Node Excision<br/>Male<br/>Middle Aged<br/>Neoplasm Invasiveness<br/>Neoplasm Recurrence, Local--pathology<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Survivin